Researcher
Katleen Vereecken
Publications
11 - 20 of 33
- MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency(2012)
Authors: K. Grupping, P Selhorst, J Michiels, K Vereecken, L Heyndrickx, P. Kessler, G Vanham, L. Martin, Kevin Ariën
Pages: 1-16 - Human Immunodeficiency Virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides(2011)
Authors: P Selhorst, AC Vazquez, K Terrazas-Aranda, J Michiels, K Vereecken, L Heyndrickx, J Weber, ME Quiñones-Mateu, Kevin Ariën, G Vanham
Pages: 1403-1413 - Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtained(2011)
Authors: SS Balla-Jhagjhoorsingh, B Willems, L Heyndrickx, L Heyndrickx, K Vereecken, W Janssens, MS Seaman, D. Corti, A Lanzavecchia, D. Davis, et al.
Pages: e25488 - HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies(2009)
Authors: T Dieltjens, N Loots, K Vereecken, K Grupping, L Heyndrickx, E Bottieau, G Vanham, D. Davis, W Janssens
Pages: 1165-1169 - Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes(2008)
Authors: D Beels, L Heyndrickx, K Vereecken, T Vermoesen, L Michiels, G Vanham, L Kestens
Pages: 99-107 - Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays(2008)
Authors: Leo Heyndrickx, Tine Vermoesen, Katleen Vereecken, J Kurth, Sandra Coppens, Laetitia Aerts, A Ohagen, Yven Van Herrewege, P Lewi, G Vanham
Pages: 166-173 - Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific t-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals(2008)
Authors: Ellen Van Gulck, G Vanham, L Heyndrickx, S Coppens, K Vereecken, D. Atkinson, Eric Florence, I Kint, ZN Berneman, V Van Tendeloo
Pages: 3561-3573 - Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins(2006)
Authors: Ellen Van Gulck, P Ponsaerts, L Heyndrickx, K Vereecken, Filip Moerman, A De Roo, Robert Colebunders, GA Van den Bosch, DR Van Bockstaele, VFI Van Tendeloo, et al.
Pages: 1818-1827 - Mother-to-child transmission of different HIV-1 subtypes among ARV naive infected pregnant women in Nigeria(2006)
Authors: GN Odaibo, DO Olaleye, L Heyndrickx, K Vereecken, Kathleen De Houwer, W Janssens
Pages: 77-80 - Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns [letter](2002)
Authors: P Nyambi, L Heyndrickx, K Vereecken, S Burda, Kathleen De Houwer, S Coppens, M Urbanski, C Williams, P. Ndumbe, W Janssens
Pages: 295-296